Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kuleana Technology is developing a portable, patient-centered hemodialysis system that does not require a constant water connection and incorporates needleless vascular access. The core innovation is the POUR system, which regenerates dialysate using photo-electrochemical urea oxidation and reactive adsorption, enabling compact, mobile dialysis. The company is progressing toward FDA 510k approval for its Dialysis Regeneration Module. No clinical trial results are yet available; the technology remains in preclinical/engineering validation stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kuleana Technology.